公开(公告)号：US20110055152A1

公开(公告)日：2011-03-03

申请号：US12872588

申请日：2010-08-31

申请人： Yun Seok Jang ,  Jae Hyun Park

发明人： Yun Seok Jang ,  Jae Hyun Park

IPC分类号： G06F15/16 ,  G06F17/30

CPC分类号： G06Q10/10 ,  H04L67/04 ,  H04L67/1095 ,  H04L67/34

摘要： Provided are a data management method, device and system for synchronizing data without prior knowledge of the data's structure. When any application is activated, application data is created and also an application data change log is created to indicate a change in the application data. In addition, a schema table defining a data structure for storing the application data is created and also a schema table change log indicating a change in the schema table is created. Based on such data and logs, a client and a server can share data without a prior agreement in data schema.

摘要翻译： 提供了一种用于在没有数据结构的知识的情况下同步数据的数据管理方法，设备和系统。 当激活任何应用程序时，创建应用程序数据，并创建应用程序数据更改日志以指示应用程序数据的更改。 此外，创建定义用于存储应用数据的数据结构的模式表，并且还创建指示模式表中的改变的模式表改变日志。 基于这样的数据和日志，客户机和服务器可以在数据模式中没有事先约定的情况下共享数据。

公开(公告)号：US08838537B2

公开(公告)日：2014-09-16

申请号：US12872588

申请日：2010-08-31

申请人： Yun Seok Jang ,  Jae Hyun Park

发明人： Yun Seok Jang ,  Jae Hyun Park

IPC分类号： G06Q10/10 ,  H04L29/08

CPC分类号： G06Q10/10 ,  H04L67/04 ,  H04L67/1095 ,  H04L67/34

摘要： Provided are a data management method, device and system for synchronizing data without prior knowledge of the data's structure. When any application is activated, application data is created and also an application data change log is created to indicate a change in the application data. In addition, a schema table defining a data structure for storing the application data is created and also a schema table change log indicating a change in the schema table is created. Based on such data and logs, a client and a server can share data without a prior agreement in data schema.

摘要翻译： 提供了一种用于在没有数据结构的知识的情况下同步数据的数据管理方法，设备和系统。 当激活任何应用程序时，创建应用程序数据，并创建应用程序数据更改日志以指示应用程序数据的更改。 此外，创建定义用于存储应用数据的数据结构的模式表，并且还创建指示模式表中的改变的模式表改变日志。 基于这样的数据和日志，客户机和服务器可以在数据模式中没有事先约定的情况下共享数据。

公开(公告)号：US10323803B2

公开(公告)日：2019-06-18

申请号：US15528023

申请日：2015-11-18

申请人： Seoul Semiconductor Co., Ltd. ,  Jae Hyun Park

发明人： Yoon Seop Lee ,  Da Hye Kim ,  Sang Hong Lee ,  Byoung Kyu Park ,  Dae Wook Kim ,  Jae Hyun Park

IPC分类号： H01L33/50 ,  F21S2/00 ,  H01L25/075 ,  H01L33/48 ,  F21S43/30 ,  F21S43/14 ,  F21S43/00 ,  F21S10/02

摘要： A light emitting device and a vehicular lamp are provided. The light emitting device comprises: a first light emitting unit; a second light emitting unit separated from the first light emitting unit; and a sidewall surrounding side surfaces of the first and second light emitting units while adjoining the side surfaces of the first and second light emitting units, wherein the first light emitting unit and the second light emitting unit emit light have different peak wavelengths.

公开(公告)号：US09731022B2

公开(公告)日：2017-08-15

申请号：US14124436

申请日：2012-05-18

申请人： Yong Il Kim ,  Kyeong Soo Kim ,  Jin Cheul Kim ,  Yo Han Kim ,  Jae Hyun Park ,  Jong Soo Woo

发明人： Yong Il Kim ,  Kyeong Soo Kim ,  Jin Cheul Kim ,  Yo Han Kim ,  Jae Hyun Park ,  Jong Soo Woo

IPC分类号： A61K31/517 ,  A61K47/02 ,  A61K47/10 ,  A61K47/12 ,  A61K47/14 ,  A61K47/26 ,  A61K47/36 ,  A61K47/44 ,  A61K9/20 ,  C07D401/12

CPC分类号： A61K47/44 ,  A61K9/2009 ,  A61K9/2013 ,  A61K9/2018 ,  A61K9/2031 ,  A61K9/2077 ,  A61K31/517 ,  A61K47/02 ,  A61K47/06 ,  A61K47/10 ,  A61K47/12 ,  A61K47/14 ,  A61K47/26 ,  A61K47/36 ,  C07D401/12

摘要： Disclosed is a pharmaceutical composition comprising an amide derivative or a pharmaceutically acceptable salt thereof and a non-metallic salt lubricant, which can be used as an effective cancer cell-growth inhibitor owing to its enhanced storage stability with no quality changes over time.

公开(公告)号：US09694007B2

公开(公告)日：2017-07-04

申请号：US13576338

申请日：2011-01-18

申请人： Jong Soo Woo ,  Jae Hyun Park ,  Yong Il Kim ,  Young Jun Na ,  Min Jung Kim ,  Yun Ah Lee

发明人： Jong Soo Woo ,  Jae Hyun Park ,  Yong Il Kim ,  Young Jun Na ,  Min Jung Kim ,  Yun Ah Lee

IPC分类号： A61K9/28 ,  A61K31/495 ,  A61K9/24 ,  A61K31/137

CPC分类号： A61K31/495 ,  A61K9/209 ,  A61K31/137 ,  A61K2300/00

摘要： An oral complex composition which comprises (i) a core comprising a swellable hydrogel-forming agent and pseudoephedrine, or a pharmaceutically acceptable salt thereof; (ii) a first coating layer encasing the core which comprises a water-soluble substance; and (iii) a second coating layer deposited on the first coating layer which comprises levocetirizine or a pharmaceutically acceptable salt thereof together with polyvinylalcohol, povidone, polyvinylalcohol-polyethyleneglycol graft copolymer or a mixture thereof, has an improved levocetirizine releasing rate and does not show a delayed release behavior even after a long storage period. Accordingly, the inventive oral complex composition is useful for treating perennial or seasonal allergic diseases including nasal obstruction, sneezing, and rhinorrhea.

公开(公告)号：US08994222B2

公开(公告)日：2015-03-31

申请号：US13178100

申请日：2011-07-07

申请人： Young Ho Ryu ,  Eun Seok Park ,  Sang Wook Kwon ,  Jung Hae Lee ,  Jae Hyun Park ,  Byung Chul Park

发明人： Young Ho Ryu ,  Eun Seok Park ,  Sang Wook Kwon ,  Jung Hae Lee ,  Jae Hyun Park ,  Byung Chul Park

IPC分类号： H01F27/42 ,  H01F37/00 ,  H01F38/00 ,  H04B5/00 ,  H02J5/00

CPC分类号： H02J50/40 ,  H01F38/14 ,  H02J5/005 ,  H02J50/12 ,  H02J50/70 ,  H02J50/90 ,  H03H7/40 ,  H04B5/0037

摘要： Provided is an apparatus that may control a direction of wireless power transmission. A radiative wireless power transmitter may include at least two first unit resonators to form a magnetic field with a target resonator based on an x-axis direction and a z-axis direction, and to transmit a resonance power to the target resonator, at least two second unit resonators to form a magnetic field with the target resonator based on the x-axis direction and a y-axis direction, and to transmit a resonance power to the target resonator, at least two third unit resonators to form a magnetic field with the target resonator based on the y-axis direction and the z-axis direction, and to transmit a resonance power to the target resonator, and a feeding unit to control resonance power transmission of the at least two first unit resonators, the at least two second unit resonators, and the at least two third unit resonators.

摘要翻译： 提供了可以控制无线电力传输的方向的装置。 辐射无线电力发射器可以包括至少两个第一单元谐振器，以基于x轴方向和z轴方向与目标谐振器形成磁场，并且向目标谐振器传输谐振电力，至少两个 第二单位谐振器，用于基于x轴方向和y轴方向与目标谐振器形成磁场，并且向目标谐振器发送谐振电力，至少两个第三单元谐振器与 基于y轴方向和z轴方向的目标谐振器，并且向目标谐振器发送谐振功率;以及馈送单元，用于控制所述至少两个第一单元谐振器的谐振功率传输，所述至少两个第二 单元谐振器和至少两个第三单元谐振器。

公开(公告)号：US08797219B2

公开(公告)日：2014-08-05

申请号：US13142937

申请日：2009-12-09

申请人： Jae Woo Ko ,  Jeong Hae Lee ,  Joon Hyun Baek ,  Jae Hyun Park

发明人： Jae Woo Ko ,  Jeong Hae Lee ,  Joon Hyun Baek ,  Jae Hyun Park

IPC分类号： H01Q1/00

CPC分类号： H01Q9/0421 ,  H01Q1/38 ,  H01Q5/40 ,  H01Q9/045 ,  H01Q21/30

摘要： The present invention relates to an infinite wavelength antenna device, which includes: a board body made of a dielectric and having a slab structure; a feed part arranged on one surface of the board body, and generating a magnetic field when power is applied; and an MNG resonance part arranged on the board body so that a preset distance is maintained from the feed part and at least a portion thereof is placed within the magnetic field, grounded through both ends thereof, resonating at a specific frequency band when the magnetic field is generated, and having a negative permeability. In the present invention, as the infinite wavelength antenna device operates according to the infinite wavelength property, the resonant frequency band may be determined independently of the size of the antenna device. Hence, miniaturization of the infinite wavelength antenna device can be realized. In addition, as power feeding is performed using magnetic coupling in the infinite wavelength antenna device, power can be easily fed to multiple resonance parts of the antenna device. Consequently, the infinite wavelength antenna device may resonate at multiple frequency bands or a wider frequency band.

摘要翻译： 无限长波长天线装置技术领域本发明涉及无限长波长天线装置，其特征在于，包括：由电介质构成的板状体， 设置在所述基板主体的一个表面上的馈电部，并且在施加电力时产生磁场; 以及布置在电路板主体上的MNG共振部分，使得从馈电部分保持预设距离，并且其至少一部分被放置在磁场内，通过其两端接地，当磁场 并且具有负导磁率。 在本发明中，随着无限波长天线装置根据无限波长特性进行工作，可以独立于天线装置的尺寸来确定谐振频带。 因此，可以实现无限波长天线装置的小型化。 此外，由于在无限波长天线装置中使用磁耦合进行供电，因此能够容易地将电力馈送到天线装置的多个谐振部。 因此，无限波长天线装置可以在多个频带或更宽的频带谐振。

公开(公告)号：US20140170213A1

公开(公告)日：2014-06-19

申请号：US14232433

申请日：2012-07-11

申请人： Yong II Kim ,  Dong Ho Kim ,  Taek Kwan Kwon ,  Kyeong Soo Kim ,  Jae Hyun Park ,  Jong Soo Woo

发明人： Yong II Kim ,  Dong Ho Kim ,  Taek Kwan Kwon ,  Kyeong Soo Kim ,  Jae Hyun Park ,  Jong Soo Woo

IPC分类号： A61K9/48 ,  A61K31/495 ,  A61K31/47

CPC分类号： A61K9/4808 ,  A61K9/1623 ,  A61K9/1635 ,  A61K9/1652 ,  A61K9/2018 ,  A61K9/2027 ,  A61K9/2054 ,  A61K9/4816 ,  A61K31/47 ,  A61K31/473 ,  A61K31/495 ,  A61K31/4965 ,  C07D215/12 ,  C07D295/06 ,  C07D295/08 ,  A61K2300/00

摘要： Disclosed is a capsule formulation for preventing or treating allergic rhinitis and asthma, which comprises two separate layers of: (1) a Montelukast layer comprising montelukast or a pharmaceutically acceptable salt thereof; and (2) a Levocetirizine layer comprising levocetirizine or a pharmaceutically acceptable salt thereof; and a method for the preparation thereof. The capsule formulation according to the present invention can completely separate two active ingredients, thereby minimizing the reactivity between them and improving product stability against aging effects, and thus, can optimize the therapeutic effects.

摘要翻译： 公开了一种用于预防或治疗过敏性鼻炎和哮喘的胶囊制剂，其包含两个单独的层：（1）包含孟鲁司特或其药学上可接受的盐的蒙特卡斯特层; 和（2）包含左西替利嗪或其药学上可接受的盐的左西替利嗪层; 及其制备方法。 根据本发明的胶囊制剂可以完全分离两种活性成分，从而最小化它们之间的反应性并提高产品对抗老化作用的稳定性，从而可以优化治疗效果。

公开(公告)号：US08584154B2

公开(公告)日：2013-11-12

申请号：US12562392

申请日：2009-09-18

申请人： Jae Hyun Park ,  Cheong Un Han

发明人： Jae Hyun Park ,  Cheong Un Han

IPC分类号： G11B17/028

CPC分类号： G11B17/0282

摘要： A turn table of a spindle motor in which a small-diameter disk can be freely attached and detached is disclosed, wherein the disk insertion unit includes an inclination portion guiding the inserted disk, and a vertical portion extensively formed from the inclination portion to the disk accommodation unit to allow an inner periphery of the disk to be brought into contact, and wherein the claw includes an inclination claw portion guiding the inserted disk and a vertical claw portion bent from the inclination claw portion to chuck the disk, and wherein an outer diameter of the vertical portion at the disk insertion unit is 14.94˜l4.96 mm and an outer diameter of the vertical claw portion at the claw is 15.17˜15.23 mm.

摘要翻译： 公开了一种主轴电动机的转台，其中小直径盘可以自由地安装和拆卸，其中盘插入单元包括引导插入盘的倾斜部分和从倾斜部到盘的广泛形成的垂直部分 容纳单元，以使盘的内周接触，并且其中所述爪包括引导插入盘的倾斜爪部分和从倾斜爪部弯曲以夹紧盘的垂直爪部，并且其中外径 的盘片插入单元的垂直部分为14.94〜1.94mm，爪部的垂直爪部的外径为15.17〜15.23mm。

公开(公告)号：US20130243872A1

公开(公告)日：2013-09-19

申请号：US13988947

申请日：2011-12-14

申请人： Yong Il Kim ,  Young Jun Na ,  Jun Young Choi ,  Min Jung Kim ,  Jae Hyun Park ,  Jong Soo Woo

发明人： Yong Il Kim ,  Young Jun Na ,  Jun Young Choi ,  Min Jung Kim ,  Jae Hyun Park ,  Jong Soo Woo

IPC分类号： A61K9/16 ,  A61K31/40 ,  G01N33/15 ,  A61K31/616

CPC分类号： A61K9/16 ,  A61K9/1611 ,  A61K9/1676 ,  A61K9/4808 ,  A61K9/5042 ,  A61K9/5047 ,  A61K9/5078 ,  A61K9/5084 ,  A61K31/22 ,  A61K31/366 ,  A61K31/40 ,  A61K31/405 ,  A61K31/47 ,  A61K31/505 ,  A61K31/616 ,  A61K45/06 ,  G01N33/15 ,  A61K2300/00

摘要： Provided is a pharmaceutical composite formulation for preventing or treating cardiovascular diseases, which comprises (1) a first particle comprising an HMG-CoA reductase inhibitor and a basic additive; and (2) a second particle comprising a core containing aspirin and an enteric coating layer coated on said core, wherein the difference in the average diameters of said first and second particles is 100 μm to 800 μm; a method for preparing same; and a method of validating the quality of same. The pharmaceutical composite formulation according to the present invention can improve the stability of an active ingredient and prevent adverse impacts between the active ingredients to thereby enable an accurate quality validation of the pharmaceutical composite formulation.

摘要翻译： 提供一种用于预防或治疗心血管疾病的药物复合制剂，其包含（1）包含HMG-CoA还原酶抑制剂和碱性添加剂的第一颗粒; 和（2）包含含有阿司匹林的芯和涂覆在所述芯上的肠溶衣层的第二颗粒，其中所述第一和第二颗粒的​​平均直径的差异为100μm至800μm; 一种制备方法; 以及验证其质量的方法。 根据本发明的药物复合制剂可以改善活性成分的稳定性并防止活性成分之间的不利影响，从而能够对药物复合制剂进行准确的质量验证。